7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $5.9B | -$391M | 0.0% | -7.8% | -$119M | $35M | $174M |
| 2024 | $6.1B | -$260M | 0.0% | -4.8% | -$71M | $35M | $188M |
| 2023 | $4.3B | -$263M | 0.0% | -5.4% | -$172M | $39M | $108M |
| 2022 | $2.4B | -$107M | 0.0% | -4.4% | -$146M | $44M | $465M |
| 2021 | $1.5B | -$406M | 0.0% | -24.5% | -$155M | $49M | $1.0B |
| 2020 | $1.2B | -$60M | 0.0% | -4.7% | -$55M | $68M | $107M |
| 2019 | $794M | -$283M | 0.0% | -13.4% | -$107M | — | — |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $1.4B | $49M | 0.0% | 0.3% | $21M | $30M | $140M |
| Dec '25 | $1.6B | -$189M | 0.0% | -12.3% | -$24M | $35M | $174M |
| Sep '25 | $1.4B | -$110M | 0.0% | -9.1% | -$21M | $35M | $172M |
| Jun '25 | $1.4B | -$104M | 0.0% | -8.3% | -$38M | $35M | $171M |
| Mar '25 | $1.5B | $12M | 0.0% | -1.4% | -$36M | $35M | $137M |
| Dec '24 | $1.5B | -$106M | 0.0% | -7.1% | $13M | $35M | $188M |
| Sep '24 | $1.5B | -$118M | 0.0% | -9.2% | -$11M | $35M | $148M |
| Jun '24 | $1.5B | -$31M | 0.0% | -2.9% | -$22M | $36M | $109M |
| Mar '24 | $1.6B | -$6M | 0.0% | -0.4% | -$51M | $37M | $112M |
| Dec '23 | $1.1B | -$230M | 0.0% | -15.6% | -$65M | $39M | $108M |
| Sep '23 | $1.1B | -$31M | 0.0% | -3.5% | -$17M | $40M | $168M |
| Jun '23 | $1.1B | -$17M | 0.0% | -2.7% | -$25M | $41M | $191M |
| Mar '23 | $1.1B | $16M | 0.0% | 0.0% | -$65M | $42M | $394M |
| Dec '22 | $370M | -$56M | 0.0% | -14.6% | -$53M | $44M | $465M |
| Sep '22 | $695M | -$31M | 0.0% | -4.2% | -$786000 | $45M | $551M |
| Jun '22 | $670M | -$21M | 0.0% | -3.1% | -$65M | $46M | $669M |
| Mar '22 | $653M | $1M | 0.0% | -0.1% | -$27M | $47M | $1.0B |
| Dec '21 | $463M | -$57M | 0.0% | -10.3% | -$52M | $49M | $1.0B |
| Sep '21 | $459M | -$36M | 0.0% | -7.8% | -$22M | $50M | $1.1B |
| Jun '21 | $499M | -$299M | 0.0% | -59.8% | -$40M | $50M | $1.1B |
How the market has priced AGL against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, Agilon Health, Inc.'s revenue has grown 37.2% per year. These are computed facts, not advice.
As of FY2025, Agilon Health, Inc. reported $35M of total debt against $174M of cash; operating income covered interest expense -69.8×.
In FY2025, gross margin was —, operating margin -7.8%, and net margin -6.6%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.